Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Titlesort ascending Journal
Impact of Diabetes on the Outcomes of Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel: A Pooled Analysis of Three Phase III Studies Clinical Genitourinary Cancer
Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study Journal of Cancer Research and Clinical Oncology
Impact of Baseline Characteristics on Extensive-stage SCLC Patients Treated with Etoposide/Carboplatin; a Secondary Analysis of a Phase III Study The Clinical Respiratory Journal
Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials International Journal of Colorectal Disease
Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data Journal for ImmunoTherapy of Cancer
Immune Checkpoint Inhibition in Marjolin Ulcer: A Case Series Journal of Immunotherapy
Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients F1000 Research
Generalizable EHR-R-REDCap pipeline for a national multi-institutional rare tumor patient registry Jamia Open
Follow‑Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under‑Reporting in Oncology Trials? Drug Safety
External validation of the prostascore model inpatients with metastatic hormone-sensitive prostate cancer recruited to the CHAARTED study BJU International
Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer Journal of Biopharmaceutical Statistics
Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study Journal of Onco-Nephrology
Estimation of Tumour Regression and Growth Rates During Treatment in Patients with Advanced Prostate Cancer: A Retrospective Analysis The Lancet Oncology
Estimation of a Suitable Number of Patients for Selective Safety Data Collection (ICH E19 Draft Guideline): When is the Safety Profile of a Drug Well Characterized? Therapeutic Innovation & Regulatory Science

Pages